Program Description: 

This is a forum to review and learn about complex lymphoma cases and discuss them in a standard way with both pathological and radiological review.  The goal of this multimodality approach is to insure that the best patient care is being delivered by Hematologists/Oncologists, Pathologists, Radiologist, and Radiation Oncologists.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 1.0  AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 
Physicians
Physician Assistants
Nurse Practitioners
Registered Nurses
Learning objectives: 
    1. For Hematology/Oncology:
      1. To improve my ability to order expensive diagnostic tests.
      2. To develop multidisciplinary treatments for patients with complex lymphoid malignancies.
      3. To improve and maintain ability to recognize the salient morphologic, immunophenotypic, and cytogenetic features of common lymphoid malignancies.
      4. To review and update learning about methods and clinical practices of the radiation oncology group in the treatment of lymphoid malignancies.
    2. For Radiology:
      1. To maintain and update knowledge about response criteria as it applies to patients with lymphoma.
    3. For Hematopathology:
      1. To maintain and update knowledge about therapeutic options and clinical trials regarding patients diagnosed in their service.
    4. For Radiation Oncology:
      1. To improve my ability to order expensive diagnostic tests.
      2. To develop multidisciplinary treatments for patients with complex lymphoid malignancies.
      3. To improve and maintain ability to recognize the salient morphologic, immunophenotypic, and cytogenetic features of common lymphoid malignancies.
      4. To review and update learning about methods and clinical practices of the radiation oncology group in the treatment of lymphoid malignancies.
Faculty & credentials: 

Activity Director:
Nirav Shah, MD

Planning Commitee Members:
Timothy Fenske, MD
Michael Holt, MD
Alexandra Harrington, MD
Christopher Schultz, MD
 

All persons in control of content have NO relevant relationships to disclose with the exception of:

NameCompanyRole
Timothy Fenske, MDCelgene, Sanofi, Seattle GeneticsConsultant
Christopher Schultz, MDPrism ImagingAdvisory Board

In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.

CME Coordinator Contact Information

Name: 
Michelle Malicki
Phone number: 
+1 (414) 805-4621
Series date: 
Monday, January 1, 2018 - 12:00pm to Monday, December 31, 2018 - 12:00pm
Series location: 
Clinical Cancer Center
9200 W. Wisconsin Ave
Conference Rm K
Milwaukee, WI 53226
United States

Sessions

Session Datesort descending
18116 Lymphoma Tumor Board Conference - January 8, 2018 01/08/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - January 22, 2018 01/22/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - February 12, 2018 02/12/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - February 26, 2018 02/26/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - March 26, 2018 03/26/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - April 9, 2018 04/09/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - April 23, 2018 04/23/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - May 14, 2018 05/14/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - June 11, 2018 06/11/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - June 25, 2018 06/25/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - July 9, 2018 07/09/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - July 23 , 2018 07/23/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - August 13, 2018 08/13/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - August 27, 2018 08/27/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - September 10, 2018 09/10/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - September 24, 2018 09/24/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - October 8, 2018 10/08/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - October 22, 2018 10/22/2018 - 12:00pm to 1:00pm
18116 Lymphoma Tumor Board Conference - November 12, 2018 11/12/2018 - 12:00pm to 1:00pm